Nevertheless, the results obtained have confirmed that the main glycosylation changes found in PSA from the aggressive PCa patients were a rise in glycan structures with α2,3-SA and with GalNAc, and it has revealed the particular PSA glycoforms that are importantly decreased or increased in the aggressive PCa samples (see Table 4). The gene discussed is KLK3; the disease is posterior cortical atrophy.